Hedge Funds Signal Tough Times Ahead (Institutional Investor)
Hedge funds have rarely been so bearish about the market. Funds’ net short position in S&P 500 futures contracts is now at the second-highest level since October 2015, according to a report from NDR, a sister company of Institutional Investor. And according to data from PivotalPath, managed futures, which are the most active trader of S&P 500 futures, now have the lowest exposure to the index since June 2017.
Wall Street Is Finally Getting Its Jeffrey Epstein Reckoning (NYMag.com)
There aren’t that many ways left to get a fuller understanding of the life of Jeffrey Epstein. The man died in 2019. His enabler, Ghislaine Maxwell, has been convicted for facilitating his sex-trafficking enterprise and is serving 20 years in prison. Prince Andrew privately settled abuse claims made against him by Virginia Giuffre. Even the fund created to compensate Epstein’s victims puts strings on the money, reportedly curbing their ability to sue some of his associates, including Maxwell.
5 Best Warren Buffett Stocks To Buy According to Hedge Funds (Insider Monkey)
In this piece, we will take a look at the five best Warren Buffett stocks to buy according to hedge funds. For more stocks, head on over to 12 Best Warren Buffett Stocks To Buy According to Hedge Funds. 5. Bank of America Corporation (NYSE:BAC): Number of Hedge Fund Investors In Q4 2022: 100. Bank of America Corporation (NYSE:BAC) is one of the largest banks in America. It is based in Charlotte, North Carolina. By the end of last year’s fourth quarter, Warren Buffett’s Berkshire Hathaway had owned one billion shares of Bank of America Corporation (NYSE:BAC) for a $33 billion stake – the second largest in its portfolio and the largest investment in the bank in our database.
Thursday 4/13 Insider Buying Report: BTTX, VRDN (Nasdaq.com)
On Monday, Better Therapeutics (BTTX)’s Frank Karbe, made a $200,000 purchase of BTTX, buying 242,424 shares at a cost of $0.82 a piece. Karbe was up about 81.8% on the purchase at the high point of today’s trading session, with BTTX trading as high as $1.50 at last check today. Better Therapeutics is trading up about 4.8% on the day Thursday. Before this latest buy, Karbe made one other buy in the past year, purchasing $104,695 shares for a cost of $2.09 each. And on Wednesday, Chief Executive Officer Scott Dunseth Myers bought $101,479 worth of Viridian Therapeutics (VRDN), buying 4,000 shares at a cost of $25.37 a piece. Before this latest buy, Myers made one other buy in the past year, purchasing $160,324 shares for a cost of $29.15 each. Viridian Therapeutics is trading up about 6.1% on the day Thursday. So far Myers is in the green, up about 6.1% on their buy based on today’s trading high of $26.91.
More Than $3M Bet On Nogin? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying (Benzinga)
Nogin: The Trade: Nogin, Inc. (NOGN) CEO and President Jonathan Huberman acquired a total 1,011,828 shares an average price of $3.00. To acquire these shares, it cost around $3.04 million. The company’s CFO, Director and Chief Technology Officer also bought the company’s shares. Heliogen: The Trade: Heliogen, Inc. (HLGN) 10% owner Patrick Soonshiong acquired a total of 1,026,051 shares at an average price of $0.25. To acquire these shares, it cost around $253.28 thousand.
